SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CYTO
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
8116 49 0 CYTO
Emcee:  Mister E Type:  Unmoderated
Introduction Market Data Compact
Does anyone have any information on Cytogen?

They are going before the FDA in July and will
hopefully get approval for one of their products.

Any information of this or anything else about the
company would be appreciated.

BERN
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8116Cytogen's Prostate Cancer Drugs Gets FDA OK DOW JONES NEWSWIRES May 8, 2006 Jim Oravetz-5/8/2006
8115Cytogen, Savient In Distribution Pact For Soltamox DOW JONES NEWSWIRES April 24,Jim Oravetz-4/24/2006
8114Progenics Buys Ownership Of JV From Cytogen DOW JONES NEWSWIRES April 24, 2006 5Jim Oravetz-4/24/2006
8113Cytogen Sees 4Q Total Pdt Sales Up 13% DOW JONES NEWSWIRES January 9, 2006 7:35 Jim Oravetz-1/9/2006
8112Cytogen Presents Preclinical Data on Lead Prostate Cancer Therapeutic Product CaJim Oravetz-11/15/2005
8111Cytogen Corporation Updates 2005 Financial Guidance PRINCETON, N.J., Oct 04, 2Jim Oravetz-10/4/2005
8110Progenics and Cytogen Report Potent Anti-Tumor Activity for Experimental ProstatJim Oravetz-9/30/2005
8109SemiOT: Others looking at PSMA targets Message 21637241Jim Oravetz-8/26/2005
8108Cytogen Corp 2Q Losses 50c/Shr Vs 30c DOW JONES NEWSWIRES August 4, 2005 7:14 a.Jim Oravetz-8/4/2005
8107SemiOT: ANTIANDROGEN, VACCINE AND COMBINATION THERAPY medpagetoday.com AbstraJim Oravetz-7/28/2005
8106Seattle Genetics and PSMA Development Company Announce Antibody-Drug Conjugate CJim Oravetz-7/22/2005
8105Seattle Genetics And PSMA Development Co Announce Antibody-Drug Conjugate CollabJim Oravetz-6/20/2005
81046/6/05 - Companies agree to develop PSMA antibody for treatment of cancer ImmuJim Oravetz-6/20/2005
8103Progenics Pharma And Cytogen Still Negotiating JV Budget DOW JONES NEWSWIRES FebJim Oravetz-3/3/2005
8102FDA Panel Rejects Lymph-Node Cancer Detection Product DOW JONES NEWSWIRES March Jim Oravetz-3/3/2005
8101OT: Prostate-Cancer Treatment Shows Promise ADD: Cyto is also looking at a vaccJim Oravetz-2/17/2005
8100Am wondering if CYTO might be interested in acquiring AVM if Combidex is approveExtra Pale-1/9/2005
8099Cytogen files $70 mln mixed shelf offering November 5, 2004 5:34pm ET (ReuterJim Oravetz-11/18/2004
8098Progenics and Cytogen Announce Award of $7.4 Million in NIH Grants for Prostate Jim Oravetz-11/10/2004
8097RECENT CORPORATE HIGHLIGHTS AND DEVELOPMENTS -- Cytogen announced today thJim Oravetz-11/10/2004
8096Sept. 21 Cytogen announced that it will present at two upcoming investor confereJim Oravetz-9/23/2004
8095New Data Demonstrates Potential Role for QUADRAMET(TM) in Acute Myeloid LeukemiaJim Oravetz-9/23/2004
8094Advanced Mag Up 37%; FDA Says Combidex Data Encouraging-Co DOW JONES NEWSWIRES JJim Oravetz-6/25/2004
8093New Data Demonstrates Survival Advantage in Advanced Prostate Cancer Patients ReJim Oravetz-6/24/2004
8092Cytogen Corporation Provides Update Regarding PROSTASCINT(R) Patent InfringementJim Oravetz-6/24/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News